Search - tctmd.com

Displaying 81 - 100 of 311

Sort: Relevancy | Date

News Opinion Off Script

Evoque and Patisiran: A Tale of Two Regulatory Journeys

Sanjay Kaul, MD

March 29, 2024

News Daily News

Biologic Winrevair Wins FDA Approval for Treatment of PAH

L.A. McKeown

March 27, 2024

News Daily News

US Sees a Surge in Cardiomyopathy-Linked Hospital Stays Among Meth Users

Caitlin E. Cox

March 18, 2024

News Conference News THT 2024

Durable 1-Year Outcomes With Coronary Sinus Shunt for HF: ALT-FLOW EFS

Michael O'Riordan

March 06, 2024

Presentation THT 2024

One Ring to Rule Them All: The Promise of Sotatercept in PH (PAH and Left Heart Disease)

Presenter: Ioana Preston

March 06, 2024

Presentation THT 2024

PADN for PH in Left Heart Disease

Presenter: Greg Lewis

March 06, 2024

Presentation THT 2024

Pulmonary Artery Denervation

Presenter: Alex M. K. Rothman

March 06, 2024

Presentation THT 2024

PH-HFpEF: Levosimendan

Presenter: Sanjiv J. Shah

March 06, 2024

Presentation THT 2024

Disaggregating Left Heart Disease-Pulmonary Hypertension

Presenter: Bradley A. Maron

March 06, 2024

Presentation THT 2024

RV-PA Coupling and PV Loops: The Art of Hemodynamics

Presenter: Ryan J. Tedford

March 06, 2024

News Conference News THT 2024

Debating the Role of T-TEER in the Sickest Patients

Michael O'Riordan

March 05, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for February 2024

Shelley Wood

March 01, 2024

News Daily News

Living Near Bars, Restaurants Linked to Greater Likelihood of HF

L.A. McKeown

February 29, 2024

News Daily News

Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective

Michael O'Riordan

February 23, 2024

News Opinion CV Team Dispatch

February 2024 Dispatch for the CV Team

L.A. McKeown

February 01, 2024

News Daily News

HeartMate 3 Use Postapproval Is Soaring—and Equitably, New Numbers Show

Yael L. Maxwell

January 10, 2024

News Daily News

AHA Selects 2023’s Leading Cardiovascular Research

Todd Neale

December 22, 2023

News Opinion CV Team Dispatch

December 2023 Dispatch for the CV Team

L.A. McKeown

December 01, 2023

News Conference News AHA 2023

DAPA-MI: Cardiometabolic Endpoints ‘Win’ With Dapagliflozin After Acute MI

Shelley Wood

November 11, 2023

News Opinion Editor's Corner AHA 2023

What’s Going to Be Hot at AHA 2023

Shelley Wood

November 07, 2023

Advertisement

Evoque and Patisiran: A Tale of Two Regulatory Journeys

Biologic Winrevair Wins FDA Approval for Treatment of PAH

US Sees a Surge in Cardiomyopathy-Linked Hospital Stays Among Meth Users

Durable 1-Year Outcomes With Coronary Sinus Shunt for HF: ALT-FLOW EFS

One Ring to Rule Them All: The Promise of Sotatercept in PH (PAH and Left Heart Disease)

PADN for PH in Left Heart Disease

Pulmonary Artery Denervation

PH-HFpEF: Levosimendan

Disaggregating Left Heart Disease-Pulmonary Hypertension

RV-PA Coupling and PV Loops: The Art of Hemodynamics

Debating the Role of T-TEER in the Sickest Patients

TCTMD’s Top 10 Most Popular Stories for February 2024

Living Near Bars, Restaurants Linked to Greater Likelihood of HF

Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective

February 2024 Dispatch for the CV Team

HeartMate 3 Use Postapproval Is Soaring—and Equitably, New Numbers Show

AHA Selects 2023’s Leading Cardiovascular Research

December 2023 Dispatch for the CV Team

DAPA-MI: Cardiometabolic Endpoints ‘Win’ With Dapagliflozin After Acute MI

What’s Going to Be Hot at AHA 2023

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content